{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:43:06Z","timestamp":1789684986904,"version":"4.0.1"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale<\/jats:title>\n                    <jats:p>Malignant pleural mesothelioma is an aggressive malignancy characterized by frequent resistance to chemo- and radiotherapy, poor outcome, and limited therapeutic options. Fibroblast growth factors (FGFs) and their receptors are potential targets for cancer therapy, but their significance in mesothelioma has remained largely undefined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To investigate the antimesothelioma potential of FGF receptor 1 (FGFR1) inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Expression of FGFs and their receptors was analyzed in mesothelioma cell lines and tissue specimens. Several cell models were used to investigate FGFR1 inhibition in vitro and in combination with cisplatin and irradiation. Mouse intraperitoneal xenotransplant models were used for in vivo validation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements and Main Results<\/jats:title>\n                    <jats:p>FGFR1, FGF2, and FGF18 were overexpressed in mesothelioma. Stimulation with FGF2 led to increased cell proliferation, migration, and transition to a more sarcomatoid phenotype in subsets of mesothelioma cell lines. In contrast, inhibition of FGFR1 by a specific kinase inhibitor or a dominant-negative FGFR1 construct led to significantly decreased proliferation, clonogenicity, migration, spheroid formation, and G1 cell cycle arrest in several mesothelioma cell lines, accompanied by apoptosis induction and decreased mitogen-activated protein kinase pathway activity. Reduced tumor growth, proliferation, mitogenic signaling, and apoptosis induction were observed in vivo. Inhibition of FGFR1 synergistically enhanced the cytotoxic effects of ionizing radiation and cisplatin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our data suggest that the malignant phenotype of mesothelioma cells depends on intact FGF signals, which should be considered as therapeutic targets with a promising chemo- and radiosensitizing potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1164\/rccm.201404-0658oc","type":"journal-article","created":{"date-parts":[[2014,9,4]],"date-time":"2014-09-04T23:22:05Z","timestamp":1409872925000},"page":"763-772","source":"Crossref","is-referenced-by-count":59,"title":["Fibroblast Growth Factor Receptor Inhibition Is Active against Mesothelioma and Synergizes with Radio- and Chemotherapy"],"prefix":"10.1093","volume":"190","author":[{"given":"Karin","family":"Schelch","sequence":"first","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"},{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mir A.","family":"Hoda","sequence":"additional","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"},{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Klikovits","sequence":"additional","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"M\u00fcnzker","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahil","family":"Ghanim","sequence":"additional","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wagner","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Garay","sequence":"additional","affiliation":[{"name":"2nd Department of Pathology, Semmelweis University, Budapest, Hungary"},{"name":"National Koranyi Institute of Pulmonology, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Laszlo","sequence":"additional","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Setinek","sequence":"additional","affiliation":[{"name":"Division of Pathology, Otto Wagner Hospital, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Dome","sequence":"additional","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"},{"name":"National Koranyi Institute of Pulmonology, Budapest, Hungary"},{"name":"Department of Thoracic Surgery, National Institute of Oncology and Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Filipits","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Pirker","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Heffeter","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Selzer","sequence":"additional","affiliation":[{"name":"Department of Radiotherapy, Medical University of Vienna, Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozsef","family":"Tovari","sequence":"additional","affiliation":[{"name":"National Koranyi Institute of Pulmonology, Budapest, Hungary"},{"name":"Department of Experimental Pharmacology, National Institute of Oncology, Budapest, Hungary; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szilvia","family":"Torok","sequence":"additional","affiliation":[{"name":"National Koranyi Institute of Pulmonology, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Kenessey","sequence":"additional","affiliation":[{"name":"2nd Department of Pathology, Semmelweis University, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Holzmann","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Grasl-Kraupp","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Marian","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Berger","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balazs","family":"Hegedus","sequence":"additional","affiliation":[{"name":"Translational Thoracic Oncology Laboratory, Division of Thoracic Surgery, Department of Surgery, and"},{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"},{"name":"MTA-SE Molecular Oncology Research Group, Hungarian Academy of Sciences, Budapest, Hungary"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Grusch","sequence":"additional","affiliation":[{"name":"Institute of Cancer Research, Department of Medicine I, Comprehensive Cancer Center Vienna, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"2026032100310061000_bib1","first-page":"718","article-title":"Latent period for malignant mesothelioma of occupational origin","volume":"34","author":"Lanphear","year":"1992","journal-title":"J Occup Med"},{"key":"2026032100310061000_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","article-title":"The European mesothelioma epidemic","volume":"79","author":"Peto","year":"1999","journal-title":"Br J Cancer"},{"key":"2026032100310061000_bib3","first-page":"347","article-title":"Pathology of diffuse malignant pleural mesothelioma","volume":"9","author":"Corson","year":"1997","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"2026032100310061000_bib4","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/00000658-199609000-00005","article-title":"Extrapleural pneumonectomy in the multimodality therapy of malignant pleural mesothelioma: results in 120 consecutive patients","volume":"224","author":"Sugarbaker","year":"1996","journal-title":"Ann Surg"},{"key":"2026032100310061000_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/sonc.2002.30237","article-title":"The epidemiology of mesothelioma","volume":"29","author":"Britton","year":"2002","journal-title":"Semin Oncol"},{"key":"2026032100310061000_bib6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","article-title":"Advances in malignant mesothelioma","volume":"353","author":"Robinson","year":"2005","journal-title":"N Engl J Med"},{"key":"2026032100310061000_bib7","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3816\/CLC.2001.n.021","article-title":"Malignant pleural mesothelioma: surgical roles and novel therapies","volume":"3","author":"Pass","year":"2001","journal-title":"Clin Lung Cancer"},{"key":"2026032100310061000_bib8","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"2026032100310061000_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.lungcan.2009.08.019","article-title":"Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with cisplatin\/pemetrexed and radiotherapy","volume":"71","author":"B\u00f6l\u00fckbas","year":"2011","journal-title":"Lung Cancer"},{"key":"2026032100310061000_bib10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jtcvs.2013.01.039","article-title":"The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11\u201314 2012, Boston, MA","volume":"145","author":"Rusch","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026032100310061000_bib11","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1200\/JCO.2006.09.7634","article-title":"Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study","volume":"25","author":"Garland","year":"2007","journal-title":"J Clin Oncol"},{"key":"2026032100310061000_bib12","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1158\/1078-0432.CCR-04-1940","article-title":"Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B","volume":"11","author":"Govindan","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2026032100310061000_bib13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1097\/JTO.0b013e3181ec18db","article-title":"A phase II study of sorafenib in malignant mesothelioma: results of Cancer and Leukemia Group B 30307","volume":"5","author":"Dubey","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2026032100310061000_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1517\/14728222.2011.566217","article-title":"Targeting fibroblast-growth-factor-receptor-dependent signaling for cancer therapy","volume":"15","author":"Heinzle","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"2026032100310061000_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001451","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"2","author":"Weiss","year":"2010","journal-title":"Sci Transl Med"},{"key":"2026032100310061000_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/12615","article-title":"Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas","volume":"23","author":"Cappellen","year":"1999","journal-title":"Nat Genet"},{"key":"2026032100310061000_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet"},{"key":"2026032100310061000_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccr.2011.01.040","article-title":"Identification of a therapeutic strategy targeting amplified FGF19 in liver cancer by oncogenomic screening","volume":"19","author":"Sawey","year":"2011","journal-title":"Cancer Cell"},{"key":"2026032100310061000_bib19","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1158\/1535-7163.MCT-08-0444","article-title":"Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition","volume":"7","author":"Fischer","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"2026032100310061000_bib20","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/sj.bjc.6605596","article-title":"Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration","volume":"102","author":"Sonvilla","year":"2010","journal-title":"Br J Cancer"},{"key":"2026032100310061000_bib21","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1158\/0008-5472.CAN-09-4479","article-title":"Targeting fibroblast growth factor receptors blocks PI3K\/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis","volume":"70","author":"Dey","year":"2010","journal-title":"Cancer Res"},{"key":"2026032100310061000_bib22","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1038\/onc.2008.61","article-title":"FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities","volume":"27","author":"Allerstorfer","year":"2008","journal-title":"Oncogene"},{"key":"2026032100310061000_bib23","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/jid.2011.177","article-title":"Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition","volume":"131","author":"Metzner","year":"2011","journal-title":"J Invest Dermatol"},{"key":"2026032100310061000_bib24","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<72::AID-PATH401>3.0.CO;2-0","article-title":"Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression","volume":"189","author":"Kumar-Singh","year":"1999","journal-title":"J Pathol"},{"key":"2026032100310061000_bib25","first-page":"1093","article-title":"Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis","volume":"18","author":"Strizzi","year":"2001","journal-title":"Int J Oncol"},{"key":"2026032100310061000_bib26","doi-asserted-by":"crossref","first-page":"25369","DOI":"10.1074\/jbc.M414498200","article-title":"Alpha-tocopheryl succinate inhibits malignant mesothelioma by disrupting the fibroblast growth factor autocrine loop: mechanism and the role of oxidative stress","volume":"280","author":"Stapelberg","year":"2005","journal-title":"J Biol Chem"},{"key":"2026032100310061000_bib27","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1158\/1538-7445.AM2012-1067","article-title":"Targeting the fibroblast growth factor receptor axis in malignant pleural mesothelioma [abstract]","volume":"72","author":"Hoda","year":"2012","journal-title":"Cancer Res"},{"key":"2026032100310061000_bib28","author":"Schelch","year":"2012"},{"key":"2026032100310061000_bib29","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0022-3565(24)37619-0","article-title":"In vitro biological characterization and antiangiogenic effects of PD 166866, a selective inhibitor of the FGF-1 receptor tyrosine kinase","volume":"286","author":"Panek","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"2026032100310061000_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1097\/JTO.0b013e31820e1a25","article-title":"Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy","volume":"6","author":"Hoda","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026032100310061000_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/carcin\/bgm202","article-title":"FGF18 in colorectal tumour cells: autocrine and paracrine effects","volume":"29","author":"Sonvilla","year":"2008","journal-title":"Carcinogenesis"},{"key":"2026032100310061000_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.18632\/oncotarget.473","article-title":"Aggressiveness of human melanoma xenograft models is promoted by aneuploidy-driven gene expression deregulation","volume":"3","author":"Mathieu","year":"2012","journal-title":"Oncotarget"},{"key":"2026032100310061000_bib33","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1073\/pnas.140210697","article-title":"Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs","volume":"97","author":"Song","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026032100310061000_bib34","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20101603","article-title":"Fibroblast growth factors and their receptors in cancer","volume":"437","author":"Wesche","year":"2011","journal-title":"Biochem J"},{"key":"2026032100310061000_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.mrrev.2011.12.003","article-title":"A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma","volume":"750","author":"Melaiu","year":"2012","journal-title":"Mutat Res"},{"key":"2026032100310061000_bib36","doi-asserted-by":"crossref","first-page":"950508","DOI":"10.1155\/2012\/950508","article-title":"Alternative splicing of fibroblast growth factor receptor IgIII loops in cancer","volume":"2012","author":"Holzmann","year":"2012","journal-title":"J Nucleic Acids"},{"key":"2026032100310061000_bib37","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/1078-0432.CCR-11-0050","article-title":"Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells","volume":"17","author":"Marshall","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2026032100310061000_bib38","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family: the complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J Biol Chem"},{"key":"2026032100310061000_bib39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.201108077","article-title":"FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior","volume":"197","author":"Chioni","year":"2012","journal-title":"J Cell Biol"},{"key":"2026032100310061000_bib40","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-12-0210","article-title":"FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor","volume":"2","author":"Guagnano","year":"2012","journal-title":"Cancer Discov"},{"key":"2026032100310061000_bib41","article-title":"Non-amplified FGFR1 is a growth driver in malignant pleural mesothelioma","author":"Marek","journal-title":"Mol Cancer Res"},{"key":"2026032100310061000_bib42","doi-asserted-by":"crossref","first-page":"3259","DOI":"10.1038\/emboj.2011.234","article-title":"Nedd4-1 binds and ubiquitylates activated FGFR1 to control its endocytosis and function","volume":"30","author":"Persaud","year":"2011","journal-title":"EMBO J"},{"key":"2026032100310061000_bib43","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/ncb2877","article-title":"Crosstalk between mTOR complexes","volume":"15","author":"Xie","year":"2013","journal-title":"Nat Cell Biol"},{"key":"2026032100310061000_bib44","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1038\/bjc.2011.132","article-title":"Akt phosphorylation on Thr308 but not on Ser473 correlates with Akt protein kinase activity in human non-small cell lung cancer","volume":"104","author":"Vincent","year":"2011","journal-title":"Br J Cancer"},{"key":"2026032100310061000_bib45","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.ajpath.2011.05.060","article-title":"Pleural mesothelioma instigates tumor-associated fibroblasts to promote progression via a malignant cytokine network","volume":"179","author":"Li","year":"2011","journal-title":"Am J Pathol"},{"key":"2026032100310061000_bib46","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2026032100310061000_bib47","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1158\/0008-5472.CAN-09-1576","article-title":"The fibroblast growth factor receptor inhibitor PD173074 blocks small cell lung cancer growth in vitro and in vivo","volume":"69","author":"Pardo","year":"2009","journal-title":"Cancer Res"},{"key":"2026032100310061000_bib48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncponc0048","article-title":"Mechanisms of disease: radiosensitization by epidermal growth factor receptor inhibitors","volume":"1","author":"Sartor","year":"2004","journal-title":"Nat Clin Pract Oncol"},{"key":"2026032100310061000_bib49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1586\/era.10.169","article-title":"Malignant pleural mesothelioma: when is radiation therapy indicated?","volume":"11","author":"van Thiel","year":"2011","journal-title":"Expert Rev Anticancer Ther"},{"key":"2026032100310061000_bib50","doi-asserted-by":"crossref","first-page":"27178","DOI":"10.1074\/jbc.M601248200","article-title":"N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding","volume":"281","author":"Duchesne","year":"2006","journal-title":"J Biol Chem"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/7\/763\/67286300\/ajrccm_190_7_763.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/190\/7\/763\/67286300\/ajrccm_190_7_763.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:31:31Z","timestamp":1774067491000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/190\/7\/763\/8505505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":50,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,10,1]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201404-0658oc","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,10]]},"published":{"date-parts":[[2014,10,1]]}}}